3-deaza-4-deoxyuridine(5116-37-0)
- Name: 3-deaza-4-deoxyuridine
- Synonyms:2(1H)-Pyridone,1-b-D-ribofuranosyl- (7CI,8CI); 1-(b-D-Ribofuranosyl)-2-pyridinone;1-(b-D-Ribofuranosyl)pyridone-(2); 1-b-D-Ribofuranosyl-2-pyridone;3-Deaza-4-deoxyuridine
- Molecular Formula:C10H13 N O5
- Molecular Weight:227.217
- CAS Registry Number:5116-37-0
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.5116-37-0 3-deaza-4-deoxyuridine
Assay:99% Appearance:powder or liquid Package:according to customer requirements Storage:store in dry dark and ventilated place Transportation:By Sea/Air/Courier Application:It is an important raw material.
Min. Order:10Gram
Supplier:Zibo Hangyu Biotechnology Development Co., Ltd [
China (Mainland)] CAS No.5116-37-0 3-deaza-4-deoxyuridine
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.5116-37-0 3-deaza-4-deoxyuridine
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:3-deaza-4-deoxyuridine
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)] CAS No.5116-37-0 3-deaza-4-deoxyuridine
Assay:97% Appearance:powder Package:according to the clients requirement Storage:Room temperature with sealed well Transportation:by sea or by air Application:Use as primary and secondary intermediate
Min. Order:0
Supplier:BOC Sciences [
United States]
Other Product
- 56433-44-4/Levoprtiline
- 104811-74-7/1,1'-[(4-Methyl-m-phenylene)bis(iminocarbonylmethylene)]bis[1-methylpiperidiniumiodide] (6CI,7CI)
- 14281-59-5/4-(morpholin-4-yl)-2-phenylquinoline
- 92664-78-3/6-Amino-9-methyl-7-[(2E)-3-methyl-5-[(1R)-1,2,3,4,4aβ,5,6,7-octahydro-1,2β,5,5-tetramethylnaphthalen-1α-yl]-2-pentenyl]-7H-purin-9-ium
- 111542-93-9/Sparfloxacin
- 87049-20-5/1-{2,5-bis[2-hydroxy-3-(4-methylpiperazin-1-yl)propoxy]phenyl}ethanone tetrahydrochloride
- 964-03-4/1H-Purinium, 2-amino-9-(2-deoxy-beta-D-erythro-pentofuranosyl)-6,9-dihydro-7-methyl-6-oxo-
- 1634-04-4/Methyl tert-butyl ether
- 2831-74-5/inositol 3-phosphate
- 152511-25-6/Ergostan-26-oic acid,5,6:21,24-diepoxy-22,27- dihydroxy-1-oxo-,ä-lactone,(5â,6â,22R,- 25R)-
- 21445-44-3/Sodium dicyanocuprate(1-)
- 2446-23-3/4-Chlorodehydromethyltestosterone
- 7399-72-6/methyl 4-amino-3-hydroxynaphthalene-2-carboxylate
- 37224-63-8/prothrombin complex concentrates
- 109513-19-1/N,N-diethyl-2-(2,4,6-trimethylphenoxy)ethanamine
- 73168-22-6/67269-08-3
- 53783-83-8/tromantadine
- 90170-96-0/Benzenamine, 4,4-methylenebis-, reaction products with glycidyl Ph ether
- 5116-37-0/3-deaza-4-deoxyuridine
- 5908-89-4/phenyl (8-methyl-8-azabicyclo[3.2.1]oct-3-yl) 1-(8-methyl-8-azabicyclo[3.2.1]oct-3-yl)tetralin-1,4-dicarboxylate; sulfuric acid; hydrate
- 10443-36-4/laurylpropylenediamine
- 78263-45-3/Syndyphalin
- 6705-28-8/Pyrazinealanine
- 77-66-7/ACETYLBROMODIETHYLACETYLCARBAMIDE
- 13071-79-9/Terbufos
- 158729-16-9/3-nitrophenyl quinoline-8-sulfonate
- 34041-14-0/Acenaphtho[1',2':3,4]cyclobuta[1,2-c]furan-7,9- dione
- 5282-43-9/2-amino-4-(1,3-benzodioxol-5-yl)-5-oxo-7-phenyl-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile
- 197787-17-0/Olean-12-en-28-oic acid,21-[[(2E,6R)-6-[[6-deoxy-4-O-[(2E,- 6R)-6-hydroxy-2,6-dimethyl-1-oxo-2,7- octadienyl]-â-D-glucopyranosyl]oxy]-2- (hydroxymethyl)-6-methyl-1-oxo-2,7- octadienyl]oxy]-16-hydroxy-3-[[O-â-Dxylopyranosyl-( 1f2)-O-6-deoxy-â-D-galactopyranosyl-( 1f6)-2-(acetylamino)-2-deoxy-â- D-glucopyranosyl]oxy]-,O-R-Larabinofuranosyl-( 1f4)-O-[â-Dglucopyranosyl-( 1f3)]-O-6-deoxy-R-Lmannopyranosyl-( 1f2)-â-D-glucopyranosyl ester,(3â,16R,21â)-
- 74038-33-8/Dipiperidinophosphinous acid butyl ester